COMMUNIQUÉS West-GlobeNewswire

AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®

29/04/2025 - 16:03

Stevie winners will be celebrated during gala event on June 10 in New York BERWYN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty [...]

FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT

29/04/2025 - 16:05

West Palm Beach, April 29, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “ Company ”), today announced that effective 4.01pm Eastern Time, on April 28, 2025, (the “Effective Time [...]

Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025

29/04/2025 - 16:39

ALK (ALKB.DC / OMX: ALK B) will publish its results for the first quarter of 2025 in the morning on Tuesday, 6 May 2025. Later on the same day, the company will host a presentation for investors and analysts at 11:00 a. [...]

Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications

29/04/2025 - 17:00

MEDIA RELEASE Agreement offers rights to commercialize proposed biosimilar of Yervoy®* for treatment of variety of cancer types, targeting net reference medicine sales of USD 2.5 billion[1] Henlius to develop and [...]

remMD Launches Glow Guide: A Smart Mobility Accessory Designed to Support Safer, Smarter Movement for Aging Adults

29/04/2025 - 17:00

remMD reveals Glow Guide, a smart mobility accessory combining location services and lighting to assist loved ones with memory loss and fall prevention at night New York, New York, April 29, 2025 (GLOBE NEWSWIRE) -- [...]

Semen & Cum Pills - Best Volume Pills of 2025 (Supplements for Bigger Loads) - By Semanax

29/04/2025 - 12:16

Limassol, Cyprus, April 29, 2025 (GLOBE NEWSWIRE) -- Particularly in the male enhancement pills industry, Semenax Volume Pills are arguably the best rated and most trusted cum pills for men wanting to increase the [...]

Regeneron Reports First Quarter 2025 Financial and Operating Results

29/04/2025 - 12:30

First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS (a) of $8.22 First quarter 2025 Dupixent ® global net sales (recorded by Sanofi) increased 19% to $3.67 billion versus [...]

Le TAR-200 en monothérapie de Johnson & Johnson permet d’atteindre un taux élevé de survie sans maladie de plus de 80 pour cent chez les patients atteints de CVNIM à haut risque papillaire et non sensibles au BCG

29/04/2025 - 12:35

Les premiers résultats de l’étude SunRISe-1 (Cohorte 4) indiquent des taux élevés de survie sans maladie pour les tumeurs papillaires de haut grade, ce qui démontre un fort potentiel de préservation de la vessie, 94 [...]

Ostarine Mk-2866 SARMs: Ostarine Cycle, Osta 2866 Benefits, Ostarine PCT, Ostarine Mk-2866 Dosage, Osta 2866 Side Effects, What Is Ostarine, Buy, Before and After By CrazyBulk

29/04/2025 - 12:45

New York , April 29, 2025 (GLOBE NEWSWIRE) -- NEW YORK, April 28, 2025: Crazy Bulk OSTA 2866: A Safe Alternative to Ostarine MK 2866 Crazy Bulk OSTA 2866 is a safe and legal substitute for Ostarine MK 2866. We now have [...]

EsoBiotec to Present Preclinical Proof-of-Concept Data for Its Off-the-Shelf ENaBL In Vivo Cell Therapy Platform at the 28th Annual Meeting of the American Society of Gene and Cell Therapy

29/04/2025 - 13:00

Poster talk will present safety and efficacy data for ENaBL-T, a lentiviral vector for in vivo engineering of BCMA CAR T cells, which supported the first in vivo BCMA CAR-T cell therapy clinical trial for patients with [...]

Cullinan Therapeutics to Initiate Study of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Sjögren’s Disease in the United States

29/04/2025 - 13:00

CLN-978 is the first and only development-stage CD19 T cell engager to receive U.S. FDA IND clearance in autoimmune diseases Sjögren’s disease represents the third indication under development for CLN-978, and is a [...]

Skye Bioscience to Participate in May Investment and Medical Conferences

29/04/2025 - 13:00

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health [...]

Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference

29/04/2025 - 13:00

MENLO PARK, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the [...]

Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences

29/04/2025 - 13:00

BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several [...]

Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases

29/04/2025 - 13:00

CAMBRIDGE, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that it will present three related posters at the upcoming 2025 [...]

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2025

29/04/2025 - 13:00

BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion [...]

Dianthus Therapeutics to Participate in Two Upcoming Investor Events

29/04/2025 - 13:00

NEW YORK and WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]

PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025

29/04/2025 - 13:00

PETACH TIKVA, Israel, April 29, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report [...]

Communiqué de presse :

29/04/2025 - 13:00

Quand chaque seconde compte : Sanofi, McLaren Racing et United Autosports s'unissent pour sensibiliser à la méningite aux 24 Heures du Mans Paris, le 29 avril 2025 . Sanofi est fière de présenter une nouvelle étape [...]